PUBLIC PREFERENCES FOR ORPHAN DRUG FUNDING: RESULTS OF SUBGROUP ANALYSES

被引：0
|
作者：
Korchagina, D.
Aballea, S. [1 ]
Millier, A. [1 ]
Thokagevistk, K. [1 ]
Toumi, M. [2 ]
机构：
[1] Creativ Ceut, Paris, France
[2] Aix Marseille Univ, Marseille, France
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.07.853
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSY39
引用
收藏
页码：S112 / S112
页数：1
相关论文
共 50 条
  • [31] EXAMINATION OF PREFERENCES ELICITED FROM THE GENERAL PUBLIC: SUBGROUP COMPARISONS OF RESULTS FROM THE TIME TRADE-OFF AND STANDARD GAMBLE INSTRUMENTS
    Iskedjian, M.
    Navarro, V
    Farah, B.
    Berbari, J.
    Walker, J. H.
    Le Lorier, J.
    VALUE IN HEALTH, 2013, 16 (03) : A35 - A35
  • [32] SOCIETAL PREFERENCES FOR FUNDING ORPHAN DRUGS IN THE UK: AN APPLICATION OF VALUE BASED PRICING USING DISCRETE CHOICE EXPERIMENT METHODS
    Bourke, S. M.
    Plumpton, C. O.
    Hughes, D. A.
    VALUE IN HEALTH, 2017, 20 (09) : A559 - A559
  • [33] Feed for Thought: Factors Predicting Public Support for Funding and Labeling Preferences of Alternative Aquafeed
    Ho, Shirley S.
    Tan, Wenqi
    Chuah, Agnes S. F.
    Chua, Pearlyn Y. Y.
    Lau, Keith X. L.
    Chan, Joshua Z. A.
    ENVIRONMENTAL COMMUNICATION-A JOURNAL OF NATURE AND CULTURE, 2023, 17 (08): : 891 - 909
  • [34] Creation and development of the public service orphan drug human botulism immune globulin
    Arnon, Stephen S.
    PEDIATRICS, 2007, 119 (04) : 785 - 789
  • [35] Association between oncology drug review times and public funding recommendations
    Gagnon, Richard
    Wong, Chelsea
    Taguedong, Eddy
    Maneesh, Parthiv
    Karim, Safiya
    Lee-Ying, Richard M.
    Ezeife, Doreen Anuli
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (28)
  • [36] Societal Preferences for Funding Orphan Drugs in the United Kingdom: An Application of Person Trade-Off and Discrete Choice Experiment Methods
    Bourke, Siobhan M.
    Plumpton, Catrin O.
    Hughes, Dyfrig A.
    VALUE IN HEALTH, 2018, 21 (05) : 538 - 546
  • [37] Credibility of subgroup analyses by socioeconomic status in public health intervention evaluations: An underappreciated problem?
    Inglis, Greig
    Archibald, Daryll
    Doi, Lawrence
    Laird, Yvonne
    Malden, Stephen
    Marryat, Louise
    McAteer, John
    Pringle, Jan
    Frank, John
    SSM-POPULATION HEALTH, 2018, 6 : 245 - 251
  • [38] Government and charity funding of cancer research: public preferences and choices (vol 13, 38, 2015)
    Shah, Koonal Kirit
    Sussex, Jon
    Hernandez-Villafuerte, Karla
    HEALTH RESEARCH POLICY AND SYSTEMS, 2015, 13
  • [39] Drug Use Stigma and Public Preferences for Public Health Versus Legal System Responses
    Kort-Butler, Lisa A.
    Tyler, Kimberly A.
    Mays, Cindy
    JOURNAL OF DRUG ISSUES, 2024,
  • [40] ORPHAN DRUG DESIGNATION: A COMPARISON OF POLICIES, PROCESSES AND RESULTS FROM THE US AND THE EU
    Shields, G. E.
    Neves, Arranhado A. C.
    Bajpai, S. K.
    VALUE IN HEALTH, 2015, 18 (03) : A305 - A305
12345